Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
27.35
+0.36 (1.33%)
At close: Aug 7, 2026, 4:00 PM EDT
27.48
+0.13 (0.48%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.41 billion as of August 7, 2026. Its market cap has increased by 174.85% in one year.
Market Cap
2.41B
Enterprise Value
1.77B
1-Year Change
174.85%
Ranking
Category
Stock Price
$27.35
ChartMarket Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.41B, an increase of 285.84%. That is a compound annual growth rate of 47.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 2.41B | -16.05% |
| Dec 31, 2025 | 2.87B | 368.78% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Precigen | 2.50B |
| Nektar Therapeutics | 2.49B |
| Hemab Therapeutics Holdings | 2.48B |
| Kailera Therapeutics | 2.47B |
| Zai Lab | 2.45B |
| Vera Therapeutics | 2.37B |
| Vericel | 2.32B |
| SELLAS Life Sciences Group | 2.32B |